EUVIMEDEUVIMED entdecken
Open Access

Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer

Siyuan Wu, Qi Zhao, Shengjuan Liu, Jiayang Kuang, Ji Zhang, Annabeth Onga, Yiwei Shen, Jiaying Wang, Hehuan Sui, Lianli Ni, Yuxin Ye, Xinyue Tu und 4 weitere

International Journal of Oncology · 14.06.2024 · 65 (2)

DOI: 10.3892/ijo.2024.5665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Oncology, online erschienen am 14.06.2024. Verfasst von Siyuan Wu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Cellular and Molecular Biology Laboratory, Affiliated Zhoushan Hospital of Wenzhou Medical University, Zhoushan, Zhejiang 316020, P.R. China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Cisplatin, Glucosides, Lung Neoplasms. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungCisplatinGlucosidesLung NeoplasmsNADPH Oxidase 5Oxidative StressAnimalsHumansMaleMiceA549 CellsAntineoplastic Combined Chemotherapy ProtocolsApoptosisCell Line, TumorCell ProliferationDrug SynergismEndoplasmic Reticulum StressGene Expression Regulation, NeoplasticReactive Oxygen SpeciesStilbenesXenograft Model Antitumor Assays

Stichwörter der Autor:innen

NAPDH oxidase 5cisplatinendoplasmic reticulum stressnon‑small cell lung cancerpolydatinreactive oxygen species

Substanzen

CisplatinGlucosidesNADPH Oxidase 5NOX5 protein, humanpolydatinReactive Oxygen SpeciesStilbenes

Autor:innen und Institutionen

  • Cellular and Molecular Biology Laboratory, Affiliated Zhoushan Hospital of Wenzhou Medical University, Zhoushan, Zhejiang 316020, P.R. China.
  • Cancer and Anticancer Drug Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang 325035, P.R. China.
  • Department of General Surgery, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325000, P.R. China.

Zitieren

APA

Wu, S., Zhao, Q., Liu, S., Kuang, J., Zhang, J., Onga, A., Shen, Y., Wang, J., Sui, H., Ni, L., Ye, Y., Tu, X., Le, H. B., Zheng, Y., Cui, R., & Zhu, W. (2024). Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer. International Journal of Oncology, 65(2). https://doi.org/10.3892/ijo.2024.5665

Vancouver

Wu S, Zhao Q, Liu S, Kuang J, Zhang J, Onga A, et al. Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer. International Journal of Oncology. 2024;65(2). doi:10.3892/ijo.2024.5665

BibTeX
@article{Wu2024,
  author = {Wu, Siyuan and Zhao, Qi and Liu, Shengjuan and Kuang, Jiayang and Zhang, Ji and Onga, Annabeth and Shen, Yiwei and Wang, Jiaying and Sui, Hehuan and Ni, Lianli and Ye, Yuxin and Tu, Xinyue and Le, Han-Bo and Zheng, Yihu and Cui, Ri and Zhu, Wangyu},
  title = {Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer},
  journal = {International Journal of Oncology},
  year = {2024},
  volume = {65},
  number = {2},
  doi = {10.3892/ijo.2024.5665}
}
Kostenlos starten →